Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.5753
+0.0187 (3.36%)
At close: Aug 29, 2025, 4:00 PM
0.5715
-0.0038 (-0.66%)
After-hours: Aug 29, 2025, 7:58 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $28.49 million as of August 29, 2025. Its market cap has decreased by -71.19% in one year.
Market Cap
28.49M
Enterprise Value
36.76M
1-Year Change
-71.19%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $28.49M, a decrease of -91.85%. That is a compound annual growth rate of -52.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 28.49M | -68.09% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.41B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |